Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ferric Carboxymaltose”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Large-scale testing (Phase 3)Looking for participantsNCT05226169
What this trial is testing

Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

Who this might be right for
Advanced Gastric Carcinoma
Asan Medical Center 330
Large-scale testing (Phase 3)Study completedNCT03957057
What this trial is testing

Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia

Who this might be right for
Postpartum Anemia NosIron-deficiency
University Medical Centre Ljubljana 300
Testing effectiveness (Phase 2)Study completedNCT01382901
What this trial is testing

Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome (RLS)
American Regent, Inc. 45
Post-approval studies (Phase 4)UnknownNCT03574311
What this trial is testing

Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery

Who this might be right for
Coronary Artery DiseasePostoperative ComplicationsAortic Valve Stenosis+2 more
Turku University Hospital 210
Post-approval studies (Phase 4)Ended earlyNCT03191201
What this trial is testing

A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.

Who this might be right for
Iron-deficiencyIron ToxicityGlucose Metabolism Disorders (Including Diabetes Mellitus)+3 more
Prof Gérard WAEBER 32
Post-approval studies (Phase 4)Ended earlyNCT02213653
What this trial is testing

Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency

Who this might be right for
Solid Cancer Metastatic DiseaseLymphoid Disease
Centre Francois Baclesse 24
Post-approval studies (Phase 4)Study completedNCT03398681
What this trial is testing

Changes in Myocardial Iron After Iron Administration

Who this might be right for
Heart FailureIron-deficiency
Fundación para la Investigación del Hospital Clínico de Valencia 53
Large-scale testing (Phase 3)Study completedNCT01131624
What this trial is testing

Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women

Who this might be right for
Anaemia
Vifor Pharma 252
Large-scale testing (Phase 3)Study completedNCT03833336
What this trial is testing

Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)

Who this might be right for
Heart Failure With Normal Ejection FractionFerropenic Anemia
Institut de Recerca Biomèdica de Lleida 72
Post-approval studies (Phase 4)Ended earlyNCT01978028
What this trial is testing

Differential Gene Expression in Patients With Heart Failure and Iron Deficiency - Effects of Ferric Carboxymaltose

Who this might be right for
Heart Failure
University of Zurich 20
Post-approval studies (Phase 4)Study completedNCT01110356
What this trial is testing

Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age

Who this might be right for
Iron Deficiency
Vifor Pharma 294
Large-scale testing (Phase 3)Study completedNCT00704028
What this trial is testing

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia

Who this might be right for
Anemia
American Regent, Inc. 161
Post-approval studies (Phase 4)UnknownNCT02243735
What this trial is testing

Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia

Who this might be right for
AnemiaColorectal CarcinomaSurgery
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 198
Large-scale testing (Phase 3)Study completedNCT02453334
What this trial is testing

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

Who this might be right for
Cancer and Chemotherapy Related Anemia
American Regent, Inc. 244
Post-approval studies (Phase 4)Study completedNCT02937454
What this trial is testing

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency

Who this might be right for
Iron DeficiencyHeart Failure
Vifor (International) Inc. 1,132
Not applicableStudy completedNCT02496377
What this trial is testing

Cross Iron (Comparative Randomized Oral Versus Systemic IRON)

Who this might be right for
Allogenic TransfusionPerioperative AnaemiaKnee Arthroplasty+1 more
University Hospital, Montpellier 100
Post-approval studies (Phase 4)Study completedNCT03380520
What this trial is testing

Effect of Intravenous FerRic carbOxymaltose oN Reverse Remodeling Following Cardiac Resynchronization Therapy

Who this might be right for
Heart Failure
Hasselt University 75
Post-approval studies (Phase 4)Not Yet RecruitingNCT07414199
What this trial is testing

The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department

Who this might be right for
Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney DiseaseIron Deficiency Anaemia Due to Dietary CausesIron Deficiency Anemia Treatment+2 more
Children's Hospital of Orange County 150
Testing effectiveness (Phase 2)Study completedNCT02469480
What this trial is testing

Intravenous Ferric Carboxymaltose vs. Oral Iron Substitution in Patients With Metastatic Colorectal Cancer (CRC) and Iron Deficiency Anemia: a Randomized Multicenter Treatment Optimization Study.

Who this might be right for
Metastatic Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 64
Large-scale testing (Phase 3)WithdrawnNCT04625530
What this trial is testing

Perioperative Management in Gynaecological Carcinoma Surgery

Who this might be right for
Gynaecological Carcinoma
University Hospital, Basel, Switzerland
Load More Results